Top 5 Heal Care Companies To Own For 2014

Stryker Corporation (SYK) announced on Monday morning that it has agreed to acquire the assets of Small Bone Innovations for $375 million.

Stryker will acquire the company is an all cash transaction worth $375 million. The total net cost of the deal will be�$285 million when tax benefits are taken into account. The deal is subject to customary closing conditions and the expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period.

Small Bone Innovations was founded in 2004 and is based in Morrisville, PA. The company focuses on small joint replacement.

Top 5 European Companies To Buy For 2015: AMREP Corp (AXR)

AMREP Corporation, incorporated on August 7, 1987, through its subsidiaries, is engaged in four business segments: the Subscription Fulfillment Services business operated by Palm Coast Data LLC (Palm Coast), the Newsstand Distribution Services business, the Product Services and Other businesses operated by Kable Media Services, Inc. and its subsidiaries (Kable) (the businesses operated by Palm Coast and Kable are collectively referred to as Media Services), and the real estate business operated by AMREP Southwest Inc. and its subsidiaries (collectively, AMREP Southwest). The Company, through its Palm Coast subsidiary, conducts its Subscription Fulfillment Services business, in which it performs subscription fulfillment and related services for publishers and other customers; through its Kable Newsstand Distribution Services subsidiary distributes periodicals nationally and in Canada and in other foreign countries, and through its Kable Product Services, Specialty Packaging Services and Staffing Resources subsidiaries, provides Internet order processing and shipment for e-commerce retailers, packaging design, procurement and product fulfillment services and temporary staffing services. In January 2013, the Company's subsidiary, had acquired certain assets of FulCircle, Inc.

Subscription Fulfillment Services

The Subscription Fulfillment Services business performs fulfillment and fulfillment-related activities, principally magazine subscription fulfillment services and ancillary services. During the fiscal year ended April 30, 2012 (fiscal 2012), it accounted for approximately 75% of Media Services revenues. In the magazine subscription fulfillment services operation, Palm Coast maintains subscriber lists and databases, processes new orders, receives and accounts for payments, prepares and transmits to each publisher�� printer the labels or tapes containing the names and addresses of subscribers for mailing each issue, handles subscriber telephone inquiries and correspondence,! prepares renewal and statement notifications for mailing, generates marketing and statistical reports, processes Internet orders and prints forms and promotional materials. List services clients are publishers for whom Palm Coast maintains client customer lists, selects names for clients who rent their lists, merges rented lists with a client�� lists to eliminate duplication for the client�� promotional mailings, and sorts and sequences mailing labels. Palm Coast performs subscription fulfillment services for approximately 450 different magazine titles for approximately 110 clients and maintains databases of approximately 41 million active subscribers for its client publishers and membership organizations.

Newsstand Distribution Services

In the Company�� Newsstand Distribution Services business, Kable distributes over 450 publications for approximately 200 publishers. Among the titles are special interest magazines, including hobbyist, celebrity, puzzle, automotive, comics, women�� service and sports magazines. In a typical month, Kable distributes approximately 47 million copies of various titles to wholesalers. Kable coordinates the movement of the publications from its publisher clients to approximately 100 independent wholesalers in North America and to wholesalers in over 80 countries globally. The wholesalers in turn sell the publications to retail chains and independent retail outlets. During fiscal 2012, the Newsstand Distribution Services business accounted for approximately 11% of Media Services revenues. Kable generates and delivers to each publisher�� printer shipping instructions with the addresses of the wholesalers and the number of copies of product to be shipped to each.

Product Services and Other

Together, Kable Product Services and Kable Specialty Packaging Services (collectively, Product Services) offer an integrated approach to electronic and traditional commerce for consumer products manufacturers, including both publ! ishing an! d non-publishing customers. The business unit provides account management by customer; design, procurement, and packaging of retail packs and point-of-purchase displays; front-end processing, including customer out-reach through e-commerce, direct mail and phone; order capturing through electronic mediums, as well as traditional call center operations, mail capture and entry; warehousing and pick/pack/ship functions, including analysis of shipping methods, and billing, as well as collection of payments tendered by credit cards, checks and cash.

As an adjunct to the Subscription Fulfillment Services business, Product Services offers fulfillment services to their publishers, including shipment of premiums (free gifts) provided to subscribers, shipment of replacement copies of newly issued magazines or purchased copies of older editions and shipment and payment processing for product advertised for sale in their publishers��magazines or associated Websites. Kable Staffing Resources (Staffing Resources) operates as a separate business, which provides temporary employees to local companies in the Fairfield, Ohio area, including its affiliate Product Services. During fiscal 2012, together, they accounted for approximately 14% of Media Services revenues in 2012.

Real Estate Operations

The Company conducts its Real Estate business through AMREP Southwest, with these activities occurring in the City of Rio Rancho and adjoining areas of Sandoval County, New Mexico. Rio Rancho consists of 91,049 acres in Sandoval County near Albuquerque, of which approximately 74,100 acres have been platted into approximately 114,680 residential and commercial lots, approximately 16,500 acres are dedicated to community facilities, roads and drainage and the remainder is unplatted land. As of April 30, 2012, approximately 91,000 of these residential and commercial lots had been sold by AMREP Southwest net of lots repurchased and those returned to AMREP Southwest by deeds in lieu of foreclosu! re. As of! April 30, 2012, AMREP Southwest owns approximately 17,350 acres in Rio Rancho, of which approximately 4,415 acres are in several areas of contiguous properties, which are being developed or are suitable for development, and approximately 2,000 acres are in areas with a concentration of ownership, where AMREP Southwest owns more than 50% of the lots in the area.

At Rio Rancho, AMREP Southwest develops both residential lots and sites for commercial and industrial use as demand warrants, and also secures entitlements for development tracts for sale to homebuilders. AMREP Southwest also owns two tracts of land in Colorado, consisting of one property of approximately 160 acres planned for approximately 400 homes that AMREP Southwest focuses to offer for sale upon obtaining all necessary entitlements, and one property of approximately 10 acres zoned for commercial use.

Advisors' Opinion:

• [By Damian Illia]

  As we can see, the firm has a higher ROE than Amrep Corporation (AXR) but is well below the one registered by US Ecology Inc. (ECOL) and Cintas Corporation (CTAS).

Top 5 Heal Care Companies To Own For 2014: VolitionRX Ltd (VNRX)

VolitionRX Limited, formerly Standard Capital Corporation, incorporated on September 24, 1998, through its wholly owned subsidiary Singapore Volition Pte Limited (Volition), is a life sciences company focused on developing blood-based diagnostic tests. As of October 12, 2011, Volition was developing a range of blood-based epigenetic cancer screening tests, which will be released for research then clinical use in Europe, North America and globally. The tests will enable doctors to screen for the general presence of cancer in the body with a single blood test, and investigate, which cancer is present in many of those cancer positive patients using a panel of tests. On October 6, 2011, the Company announced the closure of the share exchange agreement with the Company. On October 6, 2011, Volition became a wholly owned subsidiary of the Company.

Volition�� HyperGenomics technology will determine specific epigenetic signatures from cancer biopsies. The HyperGenomics range of tests will be used as a second line once cancer has been diagnosed, to determine the specific subtype of disease and to help decide the most appropriate therapy. Volition is developing a non-invasive blood test for endometriosis, based on its Nucleosomics technology.

Advisors' Opinion:

• [By Peter Graham]

  At the end of last week, small cap stocks Senesco Technologies, Inc (OTCBB: SNTI), VolitionRX Ltd (OTCMKTS: VNRX) and Micromem Technologies Inc (OTCBB: MMTIF) were all trending upwards ��ending up 13.65%, 8.73% and 7.61%, respectively, on Friday. However, it�� a new trading week with the last two trading days for the year. So what direction will these three small caps head in for the end of this year and into next year? Here is a quick look to help you decide on a trading or investment strategy:

Top 5 Heal Care Companies To Own For 2014: NxStage Medical Inc.(NXTM)

NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Its primary product, the NxStage System One, is a portable hemodialysis system used for home hemodialysis and a range of dialysis therapies for chronic home hemodialysis treatment, and the treatment of acute kidney failure and fluid overload. The NxStage System One comprises components, such as The NxStage Cycler, a compact portable electromechanical device; The NxStage Cartridge, a single-use integrated treatment cartridge; and premixed dialysate for hemodialysis applications. The company also sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD); and needles and blood tubing sets primarily to dialysis clinics for the treatment of ESRD. NxStage Medical, Inc. markets its products primaril y to dialysis clinics, nephrologists, and hospitals through distributors and sales representatives in the United States, Mexico, and Europe. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. founded in 1998 and is headquartered in Lawrence, Massachusetts.

Advisors' Opinion:

• [By John Udovich]

  Small cap dialysis stock Rockwell Medical Inc (NASDAQ: RMTI) looks set to decline when the market opens after Brean Capital initiated coverage with a sell rating and a price target of $4.00, meaning it might be time to take a closer look at what is going on with the stock along with�the performance of large cap dialysis stocks DaVita Healthcare Partners (NYSE: DVA)�and Fresenius Medical Care (NYSE: FMS) along with small cap dialysis stocks NxStage Medical, Inc (NASDAQ: NXTM).�

Top 5 Heal Care Companies To Own For 2014: Curis Inc.(CRIS)

Curis, Inc., a drug discovery and development company, focuses on the research and development of cancer therapeutics. The company, under collaboration with Genentech, Inc., is conducting a pivotal Phase II clinical trial on its lead molecule, GDC-0449 in advanced basal cell carcinoma patients, as well as various Phase II clinical trials in first-line metastatic colorectal cancer and advanced ovarian cancer patients. It is also evaluating CUDC-101, a small molecule that is in a Phase I clinical testing and is designed to target histone deacetylase, epidermal growth factor receptor, and epidermal growth factor receptor 2. In addition, Curis has a development candidate, Debio 0932, which is a Heat Shock Protein 90 or Hsp90 inhibitor. The company holds a license agreement with Debiopharm related to its Hsp90 technologies. Further, it involves in preclinical testing for the development of candidates from its targeted cancer programs. The company was founded in 2000 and is base d in Lexington, Massachusetts.

Advisors' Opinion:

• [By Monica Gerson]

  Curis (NASDAQ: CRIS) dipped 18.97% to $3.16 in the pre-market session after the company reported Q3 financial results and provided CUDC-427 development update.